Literature DB >> 29979223

Distinctive Roles and Mechanisms of Human Neutrophil Peptides in Experimental Sepsis and Acute Respiratory Distress Syndrome.

Jianfeng Wu1, Bing Han2,3, Vito Fanelli4, Xiaoyan Wen3, Yongbo Huang2, Alice Luo2,3, Mirna Ghazarian3, Dingyan Wang3, Julie Khang3, Florence Morriello3, Patricia C Liaw5, John Marshall3,6, Nanshan Zhong2,3, Xiangdong Guan1, Arthur S Slutsky2,3,6, Yimin Li2,3, Haibo Zhang2,3.   

Abstract

OBJECTIVES: To examine the effects and mechanisms of human neutrophil peptides in systemic infection and noninfectious inflammatory lung injury.
DESIGN: Prospective experimental study.
SETTING: University hospital-based research laboratory.
SUBJECTS: In vitro human cells and in vivo mouse models.
INTERVENTIONS: Wild-type (Friend virus B-type) and conditional leukocyte human neutrophil peptides transgenic mice were subjected to either sepsis induced by cecal ligation and puncture or acute lung injury by intratracheal instillation of hydrochloric acid followed by mechanical ventilation. Using human neutrophil peptides as bait, the basal cell adhesion molecule (CD239) and the purinergic P2Y purinoceptor 6 receptor were identified as the putative human neutrophil peptides receptor complex in human lung epithelial cells.
MEASUREMENTS AND MAIN RESULTS: In the cecal ligation and puncture sepsis model, Friend virus B-type mice exhibited higher systemic bacterial load, cytokine production, and lung injury than human neutrophil peptides transgenic mice. Conversely, an increased lung cytokine production was seen in Friend virus B-type mice, which was further enhanced in human neutrophil peptides transgenic mice in response to two-hit lung injury induced by hydrochloric acid and mechanical ventilation. The human neutrophil peptides-mediated inflammatory response was mediated through the basal cell adhesion molecule-P2Y purinoceptor 6 receptor signal pathway in human lung epithelial cells.
CONCLUSIONS: Human neutrophil peptides are critical in host defense against infectious sepsis by their cationic antimicrobial properties but may exacerbate tissue injury when neutrophil-mediated inflammatory responses are excessive in noninfectious lung injury. Targeting the basal cell adhesion molecule/P2Y purinoceptor 6 signaling pathway may serve as a novel approach to attenuate the neutrophil-mediated inflammatory responses and injury while maintaining the antimicrobial function of human neutrophil peptides in critical illness.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29979223     DOI: 10.1097/CCM.0000000000003265

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  5 in total

Review 1.  Therapeutic targeting of neutrophil exocytosis.

Authors:  Sergio D Catz; Kenneth R McLeish
Journal:  J Leukoc Biol       Date:  2020-01-28       Impact factor: 4.962

2.  Dual effects of human neutrophil peptides in a mouse model of pneumonia and ventilator-induced lung injury.

Authors:  Junbo Zheng; Yongbo Huang; Diana Islam; Xiao-Yan Wen; Sulong Wu; Catherine Streutker; Alice Luo; Manshu Li; Julie Khang; Bing Han; Nanshan Zhong; Yimin Li; Kaijiang Yu; Haibo Zhang
Journal:  Respir Res       Date:  2018-09-29

3.  Human Neutrophil Defensins Disrupt Liver Interendothelial Junctions and Aggravate Sepsis.

Authors:  QiXing Chen; Yang Yang; YiHang Pan; LiHua Shen; Yan Zhang; Fei Zheng; Qiang Shu; XiangMing Fang
Journal:  Mediators Inflamm       Date:  2022-07-29       Impact factor: 4.529

4.  Modulation of Human Neutrophil Peptides on P. aeruginosa Killing, Epithelial Cell Inflammation and Mesenchymal Stromal Cell Secretome Profiles.

Authors:  Qingqing Dai; Yasumasa Morita; Yongbo Huang; Patricia C Liaw; Jianfeng Wu; Julie Khang; Diana Islam; Kaijiang Yu; Yimin Li; Haibo Zhang
Journal:  J Inflamm Res       Date:  2019-12-18

Review 5.  Antioxidants as Therapeutic Agents in Acute Respiratory Distress Syndrome (ARDS) Treatment-From Mice to Men.

Authors:  Andreas von Knethen; Ulrike Heinicke; Volker Laux; Michael J Parnham; Andrea U Steinbicker; Kai Zacharowski
Journal:  Biomedicines       Date:  2022-01-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.